Reference number : 172-2020-2021-Q4-968451, amendment number : , agreement type : C, recipient legal name : PBG BioPharma Inc., recipient country : CA, recipient province : AB, recipient city : Leduc|Leduc, recipient postal code : T9E 0Z4, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Formulation, scale up and mechanism of action of a potential broad spectrum anti-viral plant isolate PBG-007, agreement title french : Formulation, mise à l'échelle et mécanisme d'action d'un isolat végétal antiviral potentiel à large spectre PBG-007, agreement number : 968451, agreement value : 220000.0, agreement start date : 2021-02-01, agreement end date : 2022-05-31, description english : This project aims to develop broad spectrum immuno-modulatory Natural Health Product to fight virus infections including COVID-19., description french : Ce projet vise à mettre au point un produit de santé naturel immuno-modulateur à large spectre pour lutter contre les infections virales, notamment la COVID-19., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada